SCHEMBL4230853

SCHEMBL4230853

CC(C)(Oc1cccc2c1ccn2Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 9/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ PLA2G2A P14555 1/20 0.45
▸ PPARG P37231 5/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ PPARD Q03181 2/20 0.44
▸ HTR6 P50406 4/20 0.44
▸ PTGES2 Q9H7Z7 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ BCHE P06276 1/20 0.41
▸ FABP2 P12104 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6085083 0.81 HTR6 (0.44) KDM4EMAPTKMT2AHTR6
SCHEMBL6087229 0.79 HTR2C (0.56) ALDH1A1KDM4EMAPTHTR6
SCHEMBL6192715 0.75 CNR2 (0.44) ALDH1A1KDM4EMAPTHTR6MAPK1
SCHEMBL4239918 0.75 PPARA (0.57) PPARAALDH1A1KDM4EHSD17B10PLA2G2A
SCHEMBL6190327 0.75 CNR2 (0.50) ALDH1A1KDM4EMEN1CYP1A2MAPT
SCHEMBL6085436 0.74 HTR6 (0.60) PPARAPPARGPPARDHTR6
SCHEMBL6192840 0.74 POLB (0.53) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL6086045 0.73 KMT2A (0.48) ALDH1A1KDM4EMAPTKMT2A
SCHEMBL9056875 0.73 HTR6 (0.55) HTR6MAPK1L3MBTL1BCHE
SCHEMBL8389282 0.71 HTR6 (0.48) PPARAPLA2G2APPARGHTR6BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689389-A4 INDOLE COMPOUNDS NAT HEALTH RESEARCH INSTITUTES (TW) 2009-06-17 — — EP disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 — — US disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 — — US disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 — — US disclosed
EP-1689389-A2 INDOLE COMPOUNDS National Health Research Institutes (TW) 2006-08-16 — — EP disclosed
WO-2005056522-A2 INDOLE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2005-06-23 — — WO disclosed
US-20050124675-A1 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2005-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124675-A1 Indole compounds PPARG, PPARD, PPARA PPARA 3/4885ALDH1A1 338/4885KDM4E 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback